CCL Home Page
Up Directory CCL 08.10.09 Cutting Edge Approaches to Drug Design 2008, London
From: chemistry-request at
To: chemistry-request at
Date: Thu Mar 27 11:47:43 2008
Subject: 08.10.09 Cutting Edge Approaches to Drug Design 2008, London

Cutting Edge Approaches to Drug Design
9 October, 2008
Russell Square, London

The Cutting Edge Approaches to Drug Design (or CEA2DD) symposia are aimed 
primarily at Medicinal Chemists and other Drug Discovery Bioscientists 
eager to discover how modern, state-of-the-art methods can accelerate 
the process of drug design. 

CEA2DD initially ran under the auspices of the Royal Society of Chemistry 
Molecular Modelling group for 5 years from 2001 to 2005 as a very 
successful series of meetings which were well supported by the community. 
Building on this success we have a renaissance, as the Molecular Graphics 
and Modelling Society takes the reinvigorated meeting under its 
metaphorical wing. 

Talks are designed for the non-specialist and topics include, and are 
in no way limited to, target identification, virtual screening, 
informatics in lead optimisation, and in silico pharmacokinetic and 
ADMET profiling.

Worked examples will demonstrate the power and practicality of such 

More information, and registration details, are available from:
All @ signs were changed to |-| to fight spam. Before you send e-mail, you need to change |-| to @
For example: change joe|-| to
Please let colleagues know about conference listingts at Computational Chemistry List Conference Page at

Please help: If you find this conference list useful but you noticed some conference missing, please consider including it here by using the Conference Submission Page. It is free but your support is welcome. You will help others!!!

Modified: Fri Mar 28 01:53:09 2008 GMT
Page accessed 5719 times since Thu Mar 27 15:47:50 2008 GMT

Please help maintain CCL: If you found that your conference is listed here, please consider supporting CCL as a Supporting Member or use other Paid Services of CCL to ensure the continuation of this useful service. We cannot do it without your help.